Article Information
History
- July 17, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Takahiro Anzai1,
- Shinji Saijou1,2,
- Yoshitsugu Ohnuki3,
- Hiroshi Kurosawa3,
- Masahiro Yasunaga1 and
- Yasuhiro Matsumura1,2,4,*
- 1Division of Developmental Therapeutics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan
- 2Research division, RIN Institute Inc, 2-5-10, Shintomi, Chuo-Ku, Tokyo, 104-0041, Japan
- 3Faculty of Life and Environmental Sciences, Graduate Faculty of Interdisciplinary Research, University of Yamanashi, 4-4-37 Takeda, Kofu, Yamanashi 400-8510, Japan
- 4Department of Immune Medicine, National Cancer Center Research Institute, National Cancer Center, 5-1-1 Tsukiji, Chuo-Ku, Tokyo 104-0045, Japan
- ↵*Correspondence; Yasuhiro Matsumura, M.D., Ph.D., Department of Immune Medicine, National Cancer Center Research Institute, National Cancer Center, 5-1-1 Tsukiji, Chuo-Ku, Tokyo 104-0045, Japan E-mail; yhmatsum{at}ncc.go.jp Phone; +81-3-3547-5201 ext.3211